news roundup
Linical and Accelovance merged to create a global CRO with a significant footprint across North America, Europe and Asia-Pacific. Under this merger, they will be called Linical and have appointed a new CEO, Vita M. Lanoce.
Advertisement
A Next Generation Sequencing Approach to Influenza Vaccine Development
Thursday, September 20, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now |
Hadassah Medical Center, a healing, teaching, and research hospital in Jerusalem, Israel, is the first medical center in the country to join the TriNetX global health research network to increase clinical trial collaboration and help pharmaceutical companies improve the protocol design and feasibility process.
As part of World Hepatitis Day activities in Ulaanbaatar, Mongolia, life sciences and healthcare blockchain company, Rymedi, presented its blockchain-based technology as the infrastructure for improving patient screening and treatment in a demonstration project.
Peter O'Donnell explores the convergence of policy and science in new vaccine R&D pursuits in Europe.
|
|